Pharmafile Logo
Pharmafocus logo
Advanced Search
Takeda

Takeda completes Nycomed acquisition, installs new chief executive

October 3, 2011
Sales and Marketing Nycomed, Takeda

Takeda Pharmaceutical Company has completed its acquisition of Nycomed and named Frank Morich as chief executive of the Zurich-based firm. …

News

Trial disappointment for AZ lung cancer drug

October 3, 2011
Research and Development, Sales and Marketing AstraZeneca, selumetinib

AstraZeneca’s lung cancer drug selumetinib has failed to hit its primary endpoint in a Phase II trial. The trial compared …

News

SHL receives Good Design Award for Molly Auto Injector

October 3, 2011
Manufacturing and Production auto injector, autoinjector, good design award, molly

SHL Group is honored to have recently received certification for the Good Design Award for its revolutionary auto injector, Molly. …

News
Press release

Jean-Pierre Garnier elected chairman of Actelion

October 3, 2011
Sales and Marketing appointment, sales and marketing

Jean-Pierre Garnier has been elected chairman of Swiss biopharmaceutical company Actelion. He has sat on the company’s board since May …

Appointment

Chinese API supplier under FDA scrutiny

October 3, 2011
Manufacturing and Production Sichuan Pharmaceutical, pharma manufacturing news

Chinese active ingredient manufacturer Sichuan Pharmaceutical has been sent a warning by the US FDA for failing to sort out …

News
Janssen's Psoriasis 360 campaign

Janssen repeats digital award success

September 30, 2011
Medical Communications PM Society Digital Awards

Janssen was once again the standout winner at last night’s PM Society’s Digital Media Awards. The pharma company beat its …

News
GSK

NICE says no to lupus treatment

September 30, 2011
Sales and Marketing Benylsta, GSK, Lupus, NICE

NICE has rejected GSK’s new lupus treatment Benlysta in draft guidance.Co-developed with biotech company HGS, the drug has been hailed …

News

Chiltern expands North American Operation with a new office in Illinois

September 30, 2011
Research and Development

 Mr. Barry Simms, Chiltern’s Country Manager, North America, commented, “Chiltern continues to look for opportunities to increase our strategic footprint …

News
Press release

Astellas abandons oral anticoagulant darexaban

September 30, 2011
Research and Development Astellas, Eliquis, Xarelto, darexaban

Astellas Pharma has abandoned the development of its oral direct factor Xa inhibitor darexaban. The Japanese firm blamed both the …

News

NICE refuses to back Sanofi’s Jevtana

September 30, 2011
Sales and Marketing Jevtana, NICE

NICE has not recommended Sanofi’s prostate cancer drug Jevtana due to its high cost and concerns over its safety data. …

News

R&D jobs in emerging markets – leaders wanted

September 29, 2011
Business Services, Research and Development Jobs, careers, pharma jobs

The globalisation of pharmaceutical research and development is creating a wave of job opportunities in emerging markets such as India …

Feature
Merck & Co

Merck pulls out of J&J consumer venture

September 29, 2011
Sales and Marketing J&J, JJ, Merc & Co, OTC

Merck & Co has exited a joint venture with J&J, selling its stake in the J&J/Merck Consumer Pharmaceuticals business to …

News

NICE blames pharma R&D model for spiralling cancer drug costs

September 29, 2011
Research and Development, Sales and Marketing Cancer, NICE, clincial trials

NICE has blamed the pharma industry’s ‘inefficient’ and increasingly costly R&D model for the rising price of cancer drugs. NICE …

News
Novartis

Novartis’ brain tumour drug Votubia launched in UK

September 29, 2011
Sales and Marketing Afinitor, Votubia

Novartis has launched its orphan drug Votubia in the UK for patients with a rare type of brain tumour. Votubia …

News

Commissioning groups want more support and less red tape

September 29, 2011
NHS reforms

Clinical Commissioning Groups are concerned by the amount of bureaucracy they face and feel they don’t have enough support, according …

News

Researchers call for European clinical trial reform

September 28, 2011
Research and Development Euorpe, clinical trials

Medical researchers are calling for regulatory red tape to be snipped away from the legal requirements around clinical trials in …

News
Gardasil

Gardasil better value for money than Cervarix, finds new study

September 28, 2011
Sales and Marketing Cervarix, Gardasil, HPV, cervical cancer

A new report by the Health Protection Agency has found that Gardasil is a more cost-effective vaccine for cervical cancer …

News

Lilly launches ‘open innovation’ drug discovery

September 28, 2011
Research and Development OIDD, TB, lilly

Lilly has launched a new open innovation platform designed to help build its pipeline and to identify new treatments for …

News

SHL to speak at the upcoming Drug Delivery Trends symposium in Korea

September 28, 2011
Manufacturing and Production auto injector, autoinjector, drugy delivery, pharmapack

SHL Marketing Director Steven Kaufman will be speaking at the upcoming Primary Packaging and Drug Delivery Trends for Injectables symposium …

Feature
Press release
Thought Leadership

Cancer costs on an ‘unaffordable trajectory’

September 28, 2011
Sales and Marketing Cancer, healthcare costs

The cost of cancer is rising too fast with new treatments giving uncertain benefits, according to a new study. A …

News
The Gateway to Local Adoption Series

Latest content

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026